State Street Spdr S P Pharmaceuticals Etf (XPH)

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Forecast

The State Street Spdr S P Pharmaceuticals Etf (XPH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $62.90, representing a -7.65% decrease from the current price of $68.12. The highest analyst price target is $64.90, and the lowest is $60.91.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month XPH Price Target

Average 60.32 (-11.44% Downside)

Is State Street Spdr S P Pharmaceuticals Etf (XPH) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	60.19	Neutral
STOCH(9,6)	73.82	Neutral
STOCHRSI(14)	85.55	Sell
MACD(12,26)	0.70	Buy
ADX(14)	18.66	Neutral
William %R	-12.18	Sell
CCI(14)	135.63	Buy

Buy: 2 · Sell: 2 · Neutral: 3Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	65.77 Buy	66.33 Buy
MA20	64.67 Buy	65.46 Buy
MA50	65.52 Buy	65.61 Buy
MA100	67.39 Buy	65.18 Buy
MA200	62.17 Buy	62.09 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, XPH could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on XPH, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 60.19 indicates that XPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 73.82 indicates that XPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 85.55 indicates that XPH is overbought. This suggests that XPH price is at or near the highest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 18.66 suggests that there may be some movement in price, but it lacks strength or conviction.
CCI (Commodity Channel Index): A CCI(14) value of 135.63 indicates that XPH is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term XPH price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about State Street Spdr S P Pharmaceuticals Etf financial reports and earnings history, State Street Spdr S P Pharmaceuticals Etf (XPH) stock could reach $69.50 by 2030, $105.36 by 2040 and $137.66 by 2050. See the projected annual prices until 2050 of the State Street Spdr S P Pharmaceuticals Etf stock below:

State Street Spdr S P Pharmaceuticals Etf (XPH) is expected to reach an average price of $88.09 in 2035, with a high prediction of $90.24 and a low estimate of $79.02. This indicates an +29.33% change from the last recorded price of $68.12.
State Street Spdr S P Pharmaceuticals Etf (XPH) stock is projected to chart a bullish course in 2040, with an average price target of $99.35, representing an +45.86% change from its current level. The forecast ranges from a conservative $93.40 to a sky-high $105.36.
Our analysts predict State Street Spdr S P Pharmaceuticals Etf (XPH) to change +76.82% by 2045, soaring from $114.20 to an average price of $120.44, potentially reaching $121.67. While $114.20 is the low estimate, the potential upside is significant.
State Street Spdr S P Pharmaceuticals Etf (XPH) stock is expected to climb by 2050, reaching an average of $137.16, a +101.37% change from its current level. However, a wide range of estimates exists, with high and low targets of $137.66 and $126.95, respectively, highlighting the market's uncertainty.

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Year by Year Forecast

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2026

The predicted value for State Street Spdr S P Pharmaceuticals Etf (XPH) in 2026 is set at an average of $62.02. Estimates vary from a peak of $74.35 to a trough of $51.26, indicating an -8.95% surge from the present price of $68.12.

Month	Average	Low	High	Change from today's price
December, 2026	$62.53	$60.91	$64.90	-8.20%

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for State Street Spdr S P Pharmaceuticals Etf (XPH) is $60.50, with a high forecast of $64.42 and a low forecast of $55.74. This indicates an -11.18% decrease from the last price of $68.12.

Month	Average	Low	High	Change from today's price
January, 2027	$61.55	$60.77	$64.42	-9.64%
February, 2027	$60.90	$57.69	$61.67	-10.60%
March, 2027	$61.00	$58.33	$62.81	-10.44%
April, 2027	$62.93	$59.61	$64.16	-7.61%
May, 2027	$59.06	$58.74	$64.31	-13.29%
June, 2027	$60.21	$55.74	$60.23	-11.60%
July, 2027	$57.13	$56.10	$60.86	-16.13%
August, 2027	$61.22	$57.24	$62.39	-10.12%
September, 2027	$62.44	$60.13	$62.93	-8.33%
October, 2027	$59.91	$59.31	$62.81	-12.05%
November, 2027	$58.97	$57.61	$62.46	-13.43%
December, 2027	$60.67	$57.52	$61.03	-10.92%

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2028

In 2028, State Street Spdr S P Pharmaceuticals Etf (XPH) is projected to reach an average price of $60.81, with a high projection of $63.65 and a low estimate of $57.97. This indicates an -10.72% fall from the last price of $68.12.

Month	Average	Low	High	Change from today's price
January, 2028	$61.37	$59.23	$62.13	-9.90%
February, 2028	$59.26	$58.71	$62.11	-13.00%
March, 2028	$61.35	$58.54	$61.45	-9.93%
April, 2028	$61.45	$61.24	$63.00	-9.78%
May, 2028	$58.40	$58.33	$62.21	-14.26%
June, 2028	$60.52	$58.21	$60.52	-11.15%
July, 2028	$60.49	$59.99	$61.60	-11.20%
August, 2028	$59.48	$57.97	$60.88	-12.67%
September, 2028	$60.11	$59.30	$61.29	-11.75%
October, 2028	$62.94	$59.36	$62.97	-7.59%
November, 2028	$62.56	$61.72	$63.28	-8.15%
December, 2028	$61.82	$61.82	$63.65	-9.24%

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2029

The 2029 price forecast for State Street Spdr S P Pharmaceuticals Etf Stock (XPH) is $60.34 on average, with a high prediction of $65.53 and a low estimate of $54.25. This represents an -11.42% decrease from the previous price of $68.12.

Month	Average	Low	High	Change from today's price
January, 2029	$56.20	$56.16	$61.82	-17.49%
February, 2029	$54.82	$54.43	$57.07	-19.52%
March, 2029	$57.25	$54.25	$57.25	-15.96%
April, 2029	$61.92	$57.13	$62.07	-9.10%
May, 2029	$61.81	$60.82	$62.93	-9.25%
June, 2029	$65.11	$61.80	$65.26	-4.41%
July, 2029	$62.53	$61.94	$65.53	-8.20%
August, 2029	$59.21	$58.95	$63.44	-13.07%
September, 2029	$60.71	$58.98	$61.35	-10.87%
October, 2029	$60.10	$59.94	$61.87	-11.77%
November, 2029	$61.98	$59.24	$62.58	-9.01%
December, 2029	$62.41	$60.71	$64.26	-8.38%

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2030

State Street Spdr S P Pharmaceuticals Etf Stock (XPH) is expected to reach an average price of $63.78 in 2030, with a high forecast of $69.50 and a low forecast of $56.42. This signifies an -6.36% decrease from the last price of $68.12.

Month	Average	Low	High	Change from today's price
January, 2030	$63.83	$61.91	$65.24	-6.28%
February, 2030	$64.94	$63.28	$66.02	-4.66%
March, 2030	$66.33	$64.14	$68.05	-2.62%
April, 2030	$67.33	$65.15	$69.50	-1.15%
May, 2030	$64.26	$63.81	$67.22	-5.66%
June, 2030	$63.64	$63.14	$64.91	-6.57%
July, 2030	$65.88	$63.57	$67.05	-3.28%
August, 2030	$64.05	$63.58	$66.23	-5.97%
September, 2030	$58.86	$56.42	$65.48	-13.59%
October, 2030	$62.30	$58.52	$62.61	-8.53%
November, 2030	$61.91	$60.26	$62.49	-9.11%
December, 2030	$62.03	$61.69	$64.11	-8.93%